P0538 Histologic remission predicts relapse in patients with Ulcerative Colitis
Sign Up to like & getrecommendations! Published in 2025 at "Journal of Crohn's and Colitis"
DOI: 10.1093/ecco-jcc/jjae190.0712
Abstract: Histologic remission is not currently established as a formal treatment target in ulcerative colitis (UC). However, growing evidence indicates that histologic activity is associated with increased rates of relapse, hospitalization, and colectomy1. We aimed to… read more here.
Keywords: clinical relapse; remission; ulcerative colitis; histologic remission ... See more keywords
Medication Withdrawal With Normal or Near-normal Histology in Ulcerative Colitis is Associated With Clinical Relapse.
Sign Up to like & getrecommendations! Published in 2024 at "Journal of clinical gastroenterology"
DOI: 10.1097/mcg.0000000000002120
Abstract: GOALS We sought to understand the clinical course and risk of dysplasia in persons with UC who achieve near or complete normalization of histology. BACKGROUND Histologic remission and normalization in ulcerative colitis (UC) is associated… read more here.
Keywords: relapse; clinical relapse; normal histology; histology ... See more keywords
Distinct blood protein profiles associated with the risk of short-term and mid/long-term clinical relapse in patients with Crohn’s disease stopping infliximab: when the remission state hides different types of residual disease activity
Sign Up to like & getrecommendations! Published in 2022 at "Gut"
DOI: 10.1136/gutjnl-2022-327321
Abstract: Objective Despite being in sustained and stable remission, patients with Crohn’s disease (CD) stopping anti-tumour necrosis factor α (TNFα) show a high rate of relapse (~50% within 2 years). Characterising non-invasively the biological profiles of… read more here.
Keywords: mid long; disease; clinical relapse; relapse ... See more keywords
HBV Relapse after Discontiniuation of Tenofovir Alafenamide or Entecavir in Non-Cirrhotic Hepatitis B e Antigen-Negative Patients
Sign Up to like & getrecommendations! Published in 2025 at "Digestive Diseases"
DOI: 10.1159/000544870
Abstract: Abstract Introduction: This study investigated the off-therapy relapse in hepatitis B e antigen (HBeAg)-negative non-cirrhotic patients who discontinued tenofovir alafenamide (TAF) or entecavir (ETV). Methods: Non-cirrhotic HBeAg-negative patients who discontinued TAF or ETV were enrolled.… read more here.
Keywords: hepatitis antigen; relapse; patients discontinued; clinical relapse ... See more keywords
Rituximab retreatment guided by CD27+ B-cell count vs. clinical relapse in anti-MAG polyneuropathy: a cost-effective approach with lower cumulative doses
Sign Up to like & getrecommendations! Published in 2025 at "Frontiers in Neurology"
DOI: 10.3389/fneur.2025.1659670
Abstract: Introduction Rituximab (RTX) is a widely used treatment for anti-MAG polyneuropathy, though standardized maintenance strategies are lacking. We aimed to compare two RTX retreatment protocols: (1) a full course (375 mg/m2/week for 4 weeks) administered… read more here.
Keywords: relapse; clinical relapse; anti mag; cell ... See more keywords
Kinetics in HBsAg after Stopping Entecavir or Tenofovir in Patients with Virological Relapse but Not Clinical Relapse
Sign Up to like & getrecommendations! Published in 2022 at "Viruses"
DOI: 10.3390/v14061189
Abstract: This study investigated the kinetics in HBsAg and the HBsAg loss rate after entecavir or tenofovir disoproxil fumarate (TDF) cessation in patients with chronic hepatitis B (CHB) who achieved virological suppression after virological relapse without… read more here.
Keywords: kinetics hbsag; entecavir tenofovir; virological relapse; clinical relapse ... See more keywords
CO:12:4 | Predicting 12-month clinical relapse in Takayasu arteritis using [18F]FDG PET and convolutional neural networks
Sign Up to like & getrecommendations! Published in 2025 at "Reumatismo"
DOI: 10.4081/reumatismo.2025.1998
Abstract: Background. Takayasu arteritis (TAK) is a large-vessel vasculitis with fluctuating disease activity and a lack of validated biomarkers for relapse prediction. While [18F]FDG PET provides diagnostic sensitivity, its prognostic role remains debated. This study aimed… read more here.
Keywords: fdg pet; clinical relapse; patients tak; class ... See more keywords
Identification of clinical and immunological factors associated with clinical relapse of pemphigus vulgaris in remission
Sign Up to like & getrecommendations! Published in 2019 at "Indian Journal of Dermatology, Venereology and Leprology"
DOI: 10.4103/ijdvl.ijdvl_89_19
Abstract: Background: Pemphigus vulgaris is a potentially fatal autoimmune epidermal blistering disease with a chronic and relapsing course. It is difficult to predict clinical relapse. Identification of clinical and immunological factors that are associated with early… read more here.
Keywords: pemphigus vulgaris; clinical relapse; remission; study ... See more keywords